Tresiba (insulin degludec) is a long-acting basal insulin used to manage blood glucose le
Tresiba (insulin degludec) is a long-acting basal insulin used to manage blood glucose levels in individuals with diabetes mellitus. It provides a steady release of insulin over 24 hours or more, helping to maintain stable blood sugar levels with once-daily dosing. Tresiba is administered via subcutaneous injection and is suitable for both type 1 and type 2 diabetes. Its prolonged duration of action offers flexibility in injection timing.
Related products